The Effect of Single Dose Methylphenidate on Neurometabolites according to COMT Gene Val158Met Polymorphism in the Patient with Attention Deficit Hyperactivity Disorder: A Study Using Magnetic Resonance Spectroscopy

키워드

참고문헌 (61)

1. Polanczyk G, "The worldwide prevalence of ADHD: a systematic review and metaregression analysis", Am J Psychiatry, 164, pp.942~948 (2007)
2. Faraone SV, "Molecular genetics of attentiondeficit", hyperactivity disorder, 2005, pp.57, 1313~1323
3. Sonuga-Barke EJ, "Causal models of attention-deficit", hyperactivity disorder: from common simple deficits to multiple developmental pathways, 2005, pp.57, 1231~1238
4. Shaw P, "Attention-deficit", hyperactivity disorder is characterized by a delay in cortical maturation, 2007, pp.104, 19649~19654
5. Faraone SV, "The worldwide prevalence of ADHD: is it an American condition?", World Psychiatry, 2, pp.104~113 (2003)
6. Chang Z, "Developmental twin study of attention problems: high heritabilities throughout development", JAMA Psychiatry, 70, pp.311~318 (2013)
7. Axelrod J, "O-methylation of epinephrine and other catechols in vitro and in vivo", Science, 126, pp.400~401 (1957)
8. Lachman HM, "Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders", Pharmacogenetics, 6, pp.243~250 (1996)
9. Lotta T, "Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme", Biochemistry, 34, pp.4202~4210 (1995)
10. Chen J, "Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain", Am J Hum Genet, 75, pp.807~821 (2004)
11. Weinshilboum RM, "Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase", Annu Rev Pharmacol Toxicol, 39, pp.19~52 (1999)
12. Bruder GE, "Catechol-O-methyltransferase (COMT)genotypes and working memory: associations with differing cognitive operations", Biol Psychiatry, 58, pp.901~907 (2005)
13. Goldberg TE, "Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val-158Met genotype and schizophrenia", Arch Gen Psychiatry, 60, pp.889~896 (2003)
14. Egan MF, "Effect of COMT Val108", 158Met genotype on frontal lobe function and risk for schizophrenia, 2001, pp.98, 6917~6922
15. Diamond A, "Genetic and neurochemical modulation of prefrontal cognitive functions in children", Am J Psychiatry, 161, pp.125~132 (2004)
16. Cheon KA, "Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attentiondeficit hyperactivity disorder", Int Clin Psychopharmacol, 23, pp.291~298 (2008)
17. Bellgrove MA, "The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD", Exp Brain Res, 163, pp.352~360 (2005)
18. Kereszturi E, "Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children", Am J Med Genet B Neuropsychiatr Genet, 147B, pp.1431~1435 (2008)
19. Barr CL, "Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder", Am J Med Genet, 88, pp.710~713 (1999)
20. Hawi Z, "No association between catechol-O-methyltransferase (COMT)gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample", Am J Med Genet, 96, pp.282~284 (2000)
21. Tahir E, "No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children", Am J Med Genet, 96, pp.285~288 (2000)
22. Cheuk DK, "Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism andattention deficit hyperactivity disorder", Behav Genet, 36, pp.651~659 (2006)
23. Gizer IR, "Candidate gene studies of ADHD: a meta-analytic review", Hum Genet, 126, pp.51~90 (2009)
24. Courvoisie H, "Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings", J Neuropsychiatry Clin Neurosci, 16, pp.63~69 (2004)
25. Husarova V, "Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit", hyperactivity disorder: a (1)H magnetic resonance spectroscopy study, 2014, pp.222, 75~83
26. Amor LB, "1H-Magnetic resonance spectroscopy study of stimulant medication effect on brain metabolites in French Canadian children with attention deficit hyperactivity disorder", Neuropsychiatr Dis Treat, 10, pp.47~54 (2014)
27. Aoki Y, "Age-related change of neurochemical abnormality in attention-deficit hyperactivity disorder: a meta-analysis", Neurosci Biobehav Rev, 37, pp.1692~1701 (2013)
28. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders", American Psychiatric Association, ~ (2000)
29. First MB, "Structured clinical interview for DSM-IV clinical version (SCID-I CV)", pp.1~87 (1997), American Psychiatric Press Inc
30. Gunay S, "The norm study, transliteral equivalence, validity, reliability of adult hyperactivity scale in Turkish adult population", Türkiye'de Psikiyatri, 8, pp.98~107 (2006)
31. Miller SA, "A simple salting out procedure for extracting DNA from human nucleated cells", Nucleic Acids Res, 16, pp.1215~ (1988)
32. Yatsuga C, "No association between catechol-O-methyltransferase (COMT) genotype and attention deficit hyperactivity disorder (ADHD) in Japanese children", Brain Dev, 36, pp.620~625 (2014)
33. Carrey N, "Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study", Clin Neuropharmacol, 26, pp.218~221 (2003)
34. Faraone SV, "The age-dependent decline of attention deficit hyperactivity disorder: a metaanalysis of follow-up studies", Psychol Med, 36, pp.159~165 (2006)
35. Soares DP, "Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications", Clin Radiol, 64, pp.12~21 (2009)
36. Guney E, "Neuroimaging methods in attention deficit hyperactivity disorder", Klinik Psikiyatri, 11, pp.84~94 (2008)
37. Amen DG, "High-resolution brain SPECT imaging in ADHD", Ann Clin Psychiatry, 9, pp.81~86 (1997)
38. Kim BN, "Methylphenidate increased regional cerebral blood flow in subjects with attention deficit", hyperactivity disorder, 2001, pp.42, 19~29
39. Fagundes AO, "Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats", Int J Dev Neurosci, 25, pp.47~51 (2007)
40. Czerniak SM, "Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review", Harv Rev Psychiatry, 21, pp.151~162 (2013)
41. Angelie E, "Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study", AJNR Am J Neuroradiol, 22, pp.119~127 (2001)
42. Jin Z, "Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study", Neurosci Lett, 315, pp.45~48 (2001)
43. Fayed N, "Evidence of brain dysfunction in attention deficit-hyperactivity disorder:a controlled study with proton magnetic resonance spectroscopy", Acad Radiol, 14, pp.1029~1035 (2007)
44. Wiguna T, "Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu", Cr, NAA, Cr, and mI, pp.Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS), Clin Neuropharmacol[DOI]
45. Kato T, "Neuronal maturation and N-acetyl-L-aspartic acid development in human fetal and child brains", Brain Dev, 19, pp.131~133 (1997)
46. Proal E, "Brain gray matter deficits at 33-year follow-up in adults with attention-deficit", hyperactivity disorder established in childhood, 2011, pp.68, 1122~1134
47. Almeida LG, "Reduced right frontal cortical thickness in children, adolescents and adults with ADHD and its correlation to clinical variables: a crosssectional study", J Psychiatr Res, 44, pp.1214~1223 (2010)
48. Kronenberg G, "Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD", Eur Arch Psychiatry Clin Neurosci, 258, pp.446~450 (2008)
49. Russell VA, "Response variability in Attention-Deficit", Hyperactivity Disorder: a neuronal and glial energetics hypothesis, 2006, pp.2, 30~
50. Yang P, "Short-TE proton magnetic resonance spectroscopy investigation in adolescents with attention-deficit hyperactivity disorder", Psychiatry Res, 181, pp.199~203 (2010)
51. Bates TE, "Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo", Neuroreport, 7, pp.1397~1400 (1996)
52. Carrey NJ, "Striatal creatine and glutamate", glutamine in attention-deficit, J Child Adolesc Psychopharmacol, pp.2007, 17[DOI]
53. Nyberg F, "Structural plasticity of the brain to psychostimulant use", Neuropharmacology, 87, pp.115~124 (2014)
54. Dietz DM, "Molecular mechanisms of psychostimulant-induced structural plasticity", Pharmacopsychiatry, 42(Suppl 1), pp.S69~S78 (2009)
55. Spencer TJ, "Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies", J Clin Psychiatry, 74, pp.902~917 (2013)
56. Bledsoe J, "A magnetic resonance imaging study of the cerebellar vermis in chronically treated and treatment-naïve children with attention-deficit", hyperactivity disorder combined type, 2009, pp.65, 620~624
57. Semrud-Clikeman M, "Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD", Neurology, 67, pp.1023~1027 (2006)
58. Sobel LJ, "Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder", Am J Psychiatry, 167, pp.977~986 (2010)
59. Shaw P, "Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder", Am J Psychiatry, 166, pp.58~63 (2009)
60. Castellanos FX, "Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit", hyperactivity disorder, 2002, pp.288, 1740~1748
61. Schmidt S, "Developmental psychopathology:Attention deficit hyperactivity disorder (ADHD)", BMC Psychiatry, 9, pp.58~ (2009)

관련 논문AI추천